All questions are shown as received by the Trust.
1. Do you use IMDC (International Metastatic Renal Cell Carcinoma Database Consortium) criteria for classifying Metastatic Renal Cell Carcinoma patients? (Yes or No)
2. If Yes, for the patients treated for Metastatic Renal Cell Carcinoma during the time period January through to March 2024, how many patients were classified as:
a. Favourable risk
b. Intermediate risk
c. Poor risk